Related Experiment Video
Updated: Aug 13, 2026
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
11.8K
[Malignant lymphoma complicated with posterior reversible encephalopathy]
Rasmus Heje Thomsen1, Kristine Zakarian, Per Boye Hansen
1pbhn@regionsjaelland.dk.
Ugeskrift for Laeger
|September 17, 2015
Summary
A patient developed posterior reversible encephalopathy syndrome (PRES) with seizures after R-ICE chemotherapy for lymphoma. This is the first reported case linking R-ICE treatment to PRES, highlighting a potential adverse effect.
Area of Science:
- Neurology
- Oncology
- Pharmacology
Background:
- Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
- Chemotherapy regimens like R-ICE (rituximab, ifosfamide, carboplatin, etoposide) are used for relapsed DLBCL.
- Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder characterized by headache, seizures, and visual disturbances.
Observation:
- A 56-year-old woman with relapsed DLBCL received R-ICE chemotherapy.
- Twenty-seven days post-treatment, she developed generalized seizures and PRES.
- MRI confirmed PRES with cerebral edema in the occipital, parietal, and frontal lobes.
Findings:
- The patient had moderate renal impairment but normal blood pressure.
- PRES symptoms resolved with full remission on follow-up MRI after four weeks.
- This case represents the first documented instance of R-ICE chemotherapy inducing PRES.
Implications:
- The R-ICE regimen may be associated with an increased risk of PRES, particularly in patients with renal impairment.
- Awareness of this potential adverse effect is crucial for oncologists and neurologists managing DLBCL patients.
- Further investigation into the mechanisms linking R-ICE and PRES is warranted to optimize patient safety.
Related Concept Videos
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:26Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...